The Danish Registry of Diabetic Retinopathy.
The Danish Registry of Diabetic Retinopathy.
复制标题
DOI：
10.2147/clep.s99507
复制
发表时间：
2016
影响因子：
3.9
通讯作者：
Andresen J
中科院分区：
文献类型：
--
作者：
Andersen N;Hjortdal JØ;Schielke KC;Bek T;Grauslund J;Laugesen CS;Lund-Andersen H;Cerqueira C;Andresen J
监测丹麦糖尿病性眼病的发展，评估糖尿病性眼病筛查项目的可及性和有效性，重点关注地区间差异。目标人群包括所有诊断为糖尿病的患者。丹麦（550万居民）约有32万名糖尿病患者，每年新增27,000名患者。丹麦糖尿病视网膜病变登记处（DiaBase）收集所有≥18岁的糖尿病患者的数据，这些患者在医院眼科和私人眼科诊所接受糖尿病眼病筛查。2014-2015年，DiaBase纳入了77,968名糖尿病患者的数据。主要变量为计算绩效指标提供数据，以监测糖尿病眼筛查的质量和糖尿病视网膜病变的发展。获得有关年龄、性别、最佳矫正视力、筛查频率、每次就诊时糖尿病视网膜病变和黄斑病变的分级、糖尿病眼病的进展/消退以及失明患病率的数据。DiaBase最新年度报告（2014-2015）数据分析显示，非糖尿病性视网膜病变、非增生性糖尿病性视网膜病变和增生性糖尿病性视网膜病变的患病率分别为78%、18%和4%。无糖尿病性黄斑病变的患者占97%。糖尿病视网膜病变消退的患者比例（20%）大于糖尿病视网膜病变进展的患者比例（10%）。在丹麦，糖尿病眼科筛查的数据收集仍在扩大。对2014-2015年期间收集的数据的分析显示，尽管丹麦新诊断为糖尿病的患者数量一直在增加，但与前一年相比，糖尿病视网膜病变的总体发病率有所下降。DiaBase是观察糖尿病性眼病筛查质量、患病率和进展/消退的有用工具。
To monitor the development of diabetic eye disease in Denmark and to evaluate the accessibility and effectiveness of diabetic eye screening programs with focus on interregional variations. The target population includes all patients diagnosed with diabetes. Denmark (5.5 million inhabitants) has ~320,000 diabetes patients with an annual increase of 27,000 newly diagnosed patients. The Danish Registry of Diabetic Retinopathy (DiaBase) collects data on all diabetes patients aged ≥18 years who attend screening for diabetic eye disease in hospital eye departments and in private ophthalmological practice. In 2014–2015, DiaBase included data collected from 77,968 diabetes patients. The main variables provide data for calculation of performance indicators to monitor the quality of diabetic eye screening and development of diabetic retinopathy. Data with respect to age, sex, best corrected visual acuity, screening frequency, grading of diabetic retinopathy and maculopathy at each visit, progression/regression of diabetic eye disease, and prevalence of blindness were obtained. Data analysis from DiaBase’s latest annual report (2014–2015) indicates that the prevalence of no diabetic retinopathy, nonproliferative diabetic retinopathy, and proliferative diabetic retinopathy is 78%, 18%, and 4%, respectively. The percentage of patients without diabetic maculopathy is 97%. The proportion of patients with regression of diabetic retinopathy (20%) is greater than the proportion of patients with progression of diabetic retinopathy (10%). The collection of data from diabetic eye screening is still expanding in Denmark. Analysis of the data collected during the period 2014–2015 reveals an overall decrease of diabetic retinopathy compared to the previous year, although the number of patients newly diagnosed with diabetes has been increasing in Denmark. DiaBase is a useful tool to observe the quality of screening, prevalence, and progression/regression of diabetic eye disease.